A Case of Intolerance to Warfarin Dosing in an Intermediate Metabolizer of CYP2C9

We report a case of intolerance to warfarin dosing due to impaired drug metabolism in a patient heterozygous for the CYP2C9*3 allele. A 30-year-old woman with an artificial cardiac pacemaker was taking warfarin to prevent thromboembolism. This patient had an extremely elevated international normaliz...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Soo-Youn, Kim, June Soo, Kim, Jong-Won
Formato: Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2005
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2810600/
https://www.ncbi.nlm.nih.gov/pubmed/16385662
http://dx.doi.org/10.3349/ymj.2005.46.6.843

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2810600/
https://www.ncbi.nlm.nih.gov/pubmed/16385662
http://dx.doi.org/10.3349/ymj.2005.46.6.843

Ejemplares similares